These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35356154)

  • 21. Targeting the tumor mutanome for personalized vaccination in a TMB low non-small cell lung cancer.
    McCann K; von Witzleben A; Thomas J; Wang C; Wood O; Singh D; Boukas K; Bendjama K; Silvestre N; Nielsen FC; Thomas G; Sanchez-Elsner T; Greenbaum J; Schoenberger S; Peters B; Vijayanand P; Savelyeva N; Ottensmeier C
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35361728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a CD8+ T-cell response to a predicted neoantigen in malignant mesothelioma.
    Sneddon S; Rive CM; Ma S; Dick IM; Allcock RJN; Brown SD; Holt RA; Watson M; Leary S; Lee YCG; Robinson BWS; Creaney J
    Oncoimmunology; 2020; 9(1):1684713. PubMed ID: 32002298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis.
    de Anta JM; Jassem E; Rosell R; Martínez-Roca M; Jassem J; Martínez-López E; Monzó M; Sánchez-Hernández JJ; Moreno I; Sánchez-Céspedes M
    Oncogene; 1997 Dec; 15(24):2951-8. PubMed ID: 9416838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of WDFY3 Neoantigens as Prognostic Markers in Longterm Survivors of Extrahepatic Cholangiocarcinoma.
    Wang Y; Jin B; Zhou N; Sun Z; Li J; Chen Q; Wu X; Zhou Y; Shi Y; Lu X; Sang X; Mao Y; Du S; Wang W; Bai C
    Curr Cancer Drug Targets; 2020; 20(11):875-886. PubMed ID: 32957886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive analysis of neoantigens derived from structural variation across whole genomes from 2528 tumors.
    Shi Y; Jing B; Xi R
    Genome Biol; 2023 Jul; 24(1):169. PubMed ID: 37461029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neoantigens Derived from Recurrently Mutated Genes as Potential Immunotherapy Targets for Gastric Cancer.
    Zhou J; Zhao W; Wu J; Lu J; Ding Y; Wu S; Wang H; Ding D; Mo F; Zhou Z; Teng L; Chen S
    Biomed Res Int; 2019; 2019():8103142. PubMed ID: 31312661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High somatic mutation and neoantigen burden are correlated with decreased progression-free survival in multiple myeloma.
    Miller A; Asmann Y; Cattaneo L; Braggio E; Keats J; Auclair D; Lonial S; ; Russell SJ; Stewart AK
    Blood Cancer J; 2017 Sep; 7(9):e612. PubMed ID: 28937974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of Neoantigens in Cancer Cells as Targets for Immunotherapy.
    Okada M; Shimizu K; Fujii SI
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene fusion neoantigens: Emerging targets for cancer immunotherapy.
    Wang Y; Shi T; Song X; Liu B; Wei J
    Cancer Lett; 2021 May; 506():45-54. PubMed ID: 33675984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Untranslated regions (UTRs) are a potential novel source of neoantigens for personalised immunotherapy.
    Sng CCT; Kallor AA; Simpson BS; Bedran G; Alfaro J; Litchfield K
    Front Immunol; 2024; 15():1347542. PubMed ID: 38558815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subunits of ARID1 serve as novel biomarkers for the sensitivity to immune checkpoint inhibitors and prognosis of advanced non-small cell lung cancer.
    Sun D; Tian L; Zhu Y; Wo Y; Liu Q; Liu S; Li H; Hou H
    Mol Med; 2020 Aug; 26(1):78. PubMed ID: 32791957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New evaluation of the tumor immune microenvironment of non-small cell lung cancer and its association with prognosis.
    Shinohara S; Takahashi Y; Komuro H; Matsui T; Sugita Y; Demachi-Okamura A; Muraoka D; Takahara H; Nakada T; Sakakura N; Masago K; Miyai M; Nishida R; Shomura S; Shigematsu Y; Hatooka S; Sasano H; Watanabe F; Adachi K; Fujinaga K; Kaneda S; Takao M; Ohtsuka T; Yamaguchi R; Kuroda H; Matsushita H
    J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35396225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA class I loss in metachronous metastases prevents continuous T cell recognition of mutated neoantigens in a human melanoma model.
    Schrörs B; Lübcke S; Lennerz V; Fatho M; Bicker A; Wölfel C; Derigs P; Hankeln T; Schadendorf D; Paschen A; Wölfel T
    Oncotarget; 2017 Apr; 8(17):28312-28327. PubMed ID: 28423700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of MUC16 Mutation With Response to Immune Checkpoint Inhibitors in Solid Tumors.
    Zhang L; Han X; Shi Y
    JAMA Netw Open; 2020 Aug; 3(8):e2013201. PubMed ID: 32845327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic and Immunological Role of FAT Family Genes in Non-Small Cell Lung Cancer.
    Feng Z; Yin Y; Liu B; Zheng Y; Shi D; Zhang H; Qin J
    Cancer Control; 2022; 29():10732748221076682. PubMed ID: 35212236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tracking Neoantigens by Personalized Circulating Tumor DNA Sequencing during Checkpoint Blockade Immunotherapy in Non-Small Cell Lung Cancer.
    Jia Q; Chiu L; Wu S; Bai J; Peng L; Zheng L; Zang R; Li X; Yuan B; Gao Y; Wu D; Li X; Wu L; Sun J; He J; Robinson BWS; Zhu B
    Adv Sci (Weinh); 2020 May; 7(9):1903410. PubMed ID: 32382482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Neoantigen Landscape of the Coding and Noncoding Cancer Genome Space.
    Lau TTY; Sefid Dashti ZJ; Titmuss E; Pender A; Topham JT; Bridgers J; Loree JM; Feng X; Pleasance ED; Renouf DJ; Schrader KA; Sun S; Ho C; Marra MA; Laskin J; Karsan A
    J Mol Diagn; 2022 Jun; 24(6):609-618. PubMed ID: 35367630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of PTPRT mutations with immune checkpoint inhibitors response and outcome in melanoma and non-small cell lung cancer.
    Zhang W; Shi F; Kong Y; Li Y; Sheng C; Wang S; Wang Q
    Cancer Med; 2022 Feb; 11(3):676-691. PubMed ID: 34862763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenic neoantigens derived from gene fusions stimulate T cell responses.
    Yang W; Lee KW; Srivastava RM; Kuo F; Krishna C; Chowell D; Makarov V; Hoen D; Dalin MG; Wexler L; Ghossein R; Katabi N; Nadeem Z; Cohen MA; Tian SK; Robine N; Arora K; Geiger H; Agius P; Bouvier N; Huberman K; Vanness K; Havel JJ; Sims JS; Samstein RM; Mandal R; Tepe J; Ganly I; Ho AL; Riaz N; Wong RJ; Shukla N; Chan TA; Morris LGT
    Nat Med; 2019 May; 25(5):767-775. PubMed ID: 31011208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
    Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
    JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.